163MO Single-cell T Cell Dynamics Induced by Neoadjuvant Nivolumab +/- Ipilimumab in Early Triple Negative Breast Cancer with Tumor-Infiltrating Lymphocytes (BELLINI Trial)
Immuno-Oncology and Technology（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined